Development of acromegaly during treatment of hyperprolactinemia with bromocriptine: An unusual acidophil stem cell adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4484-4487

  Page, M D ^c   Bridges, L R ^a   Barth, J H ^a   McNichol, A M ^b   Belchetz, P E ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; PROLACTIN;

ACROMEGALY; ADENOMA; ADULT; AMENORRHEA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; PRIORITY JOURNAL;

ACROMEGALY; ADENOMA, ACIDOPHIL; ADULT; BROMOCRIPTINE; FEMALE; GROWTH HORMONE; HORMONE ANTAGONISTS; HUMANS; HYPERPROLACTINEMIA; PITUITARY NEOPLASMS;

EID: 0029829390     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4484     Document Type: Article

References (14)

1. Asa SL, Kovacs K. 1983 Histological classification of pituitary disease. Clin Endocrinol Metab. 13:567-596.
2. Horvarth E, Kovacs K, Singer W, et al. 1981 Acidophil stem cell adenoma of the human pituitary. Cancer. 47:761-771.
3. Marks WA, Brumback RA, Schaefer GB, Pendleton BD, Farris BK, Culbertson JL. 1989 Acidophil stem-cell pituitary adenoma in a pre-pubescent female. Case report. J Neurosurg. 70:266-270.
4. Kovacs K, Horvarth E. 1986 Tumors of the pituitary gland. In: Atlas of tumor pathology, 2nd series. Washington DC: Armed Forces Institute of Pathology; Fascicle 21:122-128.
5. Heidvall K, Hulting AL. 1987 Rapid progression of a growth hormone producing tumor during dopamine agonist treatment. Br Med J. 294:546-547.
6. Belchetz PE. 1984 Overview: treatment of acromegaly. In: Belchetz PE, ed. Management of pituitary disease. London: Chapman and Hall Medical; 373-376.
7. Badawy SZA, Anderson GH, Schende MC, Marshall L. 1984 Development of acromegaly in a patient with prolactinaemia: a case study. Fertil Steril. 42:926-928.
8. Badawy SZA, Nusbaum ML, Omar M. 1980 Hypothalamic pituitary evaluation in patients with galactorrhoea-amenorrhoea and hyperprolactinaemia. Obstet Gynecol. 55:1-7.
9. Scanlon MF, Peters JR, Thomas JP, et al. 1985 Management of selected patients with hyperprolactinaemia by partial hypophysectomy. Br Med J. 291:1547-1550.
10. Sarkar DK, Gottschall PE, Meitas J. 1984 Decline of tuberoinfundibular dopaminergic function resulting from chronic hyperprolactinaemia in rats. Endocrinology. 115:1269-1274.
11. Scanlon MF, Rodriguez-Arnao MD, McGregor AM et al. 1981 Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clin Endocrinol (Oxf). 14:133-143.
12. Dieguez C, Page MD, Scanlon MF. 1988 Growth hormone neuroregulation and it's alterations in disease states. Clin Endocrinol (Oxf). 28:109-143.
13. Evans RM, Birnberg NC, Rosenfeld MG. 1982 Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression. Proc Natl Acad Sci USA. 79:7659-7665.
14. Barinaga M, Yamamoto G, Rivier C, Vale W, Evans E, Rosenfeld MG. 1983 Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature. 306:84-86.